Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.59
-0.23 (-3.37%)
Aug 13, 2025, 4:00 PM - Market closed
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 71 employees as of December 31, 2024. The number of employees decreased by 29 or -29.00% compared to the previous year.
Employees
71
Change (1Y)
-29
Growth (1Y)
-29.00%
Revenue / Employee
$207,099
Profits / Employee
-$684,507
Market Cap
60.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VRCA News
- 1 day ago - Verrica Pharmaceuticals Inc. (VRCA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025 - GlobeNewsWire
- 5 weeks ago - Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - GlobeNewsWire
- 6 weeks ago - Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 3 months ago - Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call - Seeking Alpha
- 3 months ago - Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results - GlobeNewsWire